Mersana Therapeutics, Inc. (31) | Uncategorized (7)

Recent Contracts

Offer Letter, dated June 15, 2021, between the Company and Tushar Misra (Filed With SEC on May 9, 2022)
Offer Letter, dated March 5, 2021, between the Company and Alejandra Carvajal (Filed With SEC on May 9, 2022)
Offer Letter, by and between Mersana Therapeutics, Inc. and Arvin Yang, dated November 5, 2020 (Filed With SEC on May 10, 2021)
Amended and Restated Offer Letter, by and between Mersana Therapeutics, Inc. and Michael Kaufman, dated March 8, 2017 (Filed With SEC on May 10, 2021)
Offer Letter, by and between Mersana Therapeutics, Inc. and Dirk Huebner, dated November 5, 2018 (Filed With SEC on May 8, 2020)
Offer Letter, by and between Mersana Therapeutics, Inc. and Brian DeSchuytner, dated June 10, 2019 (Filed With SEC on May 8, 2020)
Offer Letter, by and between Mersana Therapeutics, Inc. and David Spellman, dated December 18, 2017 (Filed With SEC on May 9, 2019)